Key result
A cell-based FRET sensor demonstrated significant variations in substrate cleavage efficiency both within and between norovirus genogroups, highlighting differences in protease substrate recognition.
Significant variations in substrate cleavage exist between human and murine norovirus proteases, suggesting caution when using the murine model for testing protease inhibitors against human norovirus.
Answers are grounded in this paper and cite their sources.
Warrants caution extrapolating murine norovirus protease inhibitor data to humans; leaves open need for human-specific validation assays.
The viral protease represents a key drug target for the development of antiviral therapeutics. Because many protease inhibitors mimic protease substrates, differences in substrate recognition between proteases may affect their sensitivity to a given inhibitor. Here we use a cell-based FRET sensor to investigate the activity of different norovirus proteases upon cleavage of various norovirus cleavage sites inserted into a linker region separating cyan fluorescent protein and yellow fluorescent protein. Using this system, we demonstrate that differences in substrate processing exist between proteases from human noroviruses (genogroups I (GI) and II) and the commonly used murine norovirus (MNV, genogroup V) model. These altered the cleavage efficiency of specific cleavage sites both within and between genogroups. The differences observed between these proteases may affect sensitivity to protease inhibitors and the suitability of MNV as a model system for testing such molecules against the human norovirus protease. Finally, we demonstrate that replacement of MNV polyprotein cleavage sites with the GI or GII equivalents, with the exception of the NS6-7 junction, leads to the production of infectious virus when the MNV NS6 protease, but not the GI or GII proteases, are present.
No takes yet. Share an insight, caveat, or question.
Emmott et al. (2015) studied Norovirus. Norovirus proteases was evaluated on Polyprotein cleavage efficiency. A cell-based FRET sensor demonstrated significant variations in substrate cleavage efficiency both within and between norovirus genogroups, highlighting differences in protease substrate recognition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: